Skip to main content

Table 4 Demographic and clinical variables predictive of recurrence in patients with haemoptysis

From: Long-term prognostic outcomes in patients with haemoptysis

 

Univariate analysis

Multivariate analysis

OR (95% CI)

p-value

OR (95% CI)

p-value

Age (years)

 < 40

Ref.

Ref.

  

 40–54

1.3 (0.4–4.4)

0.63

  

 55–70

1.6 (0.5–5.0)

0.41

  

 > 70

1.9 (0.7–5.7)

0.23

  

Sex male

0.9 (0.6–1.3)

0.51

  

Severity of haemoptysis

 Mild

Ref.

Ref.

  

 Moderate

1.2 (0.8–2.0)

0.39

  

 Severe

1.2 (0.8–2.0)

0.35

  

Smoking history

 ≥ 10 pack/years

0.7 (0.4–1.1)

0.09

  

 ≥ 30 pack/years

0.9 (0.5–1.6)

0.74

  

Antiplatelet therapy

0.9 (0.5–1.5)

0.69

  

Anticoagulant therapy

1.1 (0.6–2.2)

0.75

  

Antiplatelet + anticoagulant therapy

1.0 (0.6–1.6)

0.98

  

Pneumonia/lung abscess

0.7 (0.4–1.3)

0.25

  

Malignancy (primary and metastatic)

1.1 (0.6–1.9)

0.79

  

Bronchiectasis

2.6 (1.5–4.3)

 < 0.0001

  

Acute bronchitis

0.6 (0.3–1.3)

0.18

  

Cryptogenic haemoptysis

1.0 (0.5–2.1)

0.94